Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le
… ProQR Supports Rare Disease Day 2018 and Honors Henri A. … the legacy of the late Henri A. Termeer, co-founder of ProQR, being held on the same day in Boston, MA. Henri … Genzyme and a visionary and pioneer for rare diseases, was ProQR’s co-founder in 2012 and vice chairman of the …
… ProQR Announces Webcast of Presentation at Upcoming HC … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under ‘Events’, beginning January 11, 2021. …
… ProQR to Host R&D Day in New York on January 29 LEIDEN, Netherlands & CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) will host a Research & … ET at the Lotte New York Palace Hotel in New York, NY. The R&D day will feature presentations by internal ProQR and …